Comment from Anonymous

AnonymousOpposeIndividual
Summary: The commenter opposes the proposed action, arguing that it is designed to protect the profits of large corporations rather than public health. They claim the measure will restrict access to cheaper, out-of-pocket compounding medications in favor of more expensive "name brand" services controlled by insurance companies.
Not concerned for public health, only monetary gain. This is designed to make the only route that citizens are capable of looking after their health, be through services that are deemed authorized through agencies and insurance companies that control costs and copays to maximize profits. People are able to pay out of pocket for these compounding companies services at much cheaper rates than "name brands" which obviously cuts into profit margins of these large companies. This measure isn't about public health or even about making sure compounding companies are legitimate.... its about taking away accessible public healthcare at cheaper prices, to put money into mega corporation pockets.

View on Regulations.gov